Development Biotechnology sustainable cell culture
Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint
Search
From prevention to prediction
What's the future of livestock farming?
Science Focus
Science Focus
Metabolic Diseases
Metabolic Diseases
Skin Diseases
Skin Diseases
Boehringer Ingelheim unites dermatologists to discuss the management of Generalized Pustular Psoriasis (GPP)
The ‘GPP Summit, discussed latest research and advances in the management of GPP to help improve patient outcomes across Saudi Arabia, and the United Arab Emirates.
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
EFPIA Mission Possible
This new video highlights how treatments once known for type 2 diabetes are now helping to prevent heart failure, stroke or kidney disease.
First hospital uae and gcc receive international award stroke management
Ibrahim Bin Hamad Obaidullah Hospital Receives the Diamond Award from the World Stroke Organization
Employees empower small dairy producers
Boehringer Ingelheim social intrapreneurship helps farmers improve animal welfare and the well-being of rural communities in Southern India.
Leading experts shed light on importance of establishing dedicated stroke management centers
Leading experts shed light on importance of establishing dedicated stroke management centers across healthcare facilities
Transboundary and emerging diseases
Through constant surveillance, research and rapid development, our Veterinary Public Health (VPH) Center fulfills a powerful purpose.
Heart Diseases
Heart Diseases
MEDEX and CRM summit discuss latest advances in CRM care
More than 300 regional experts gather in Cairo for Boehringer Ingelheim’s Forums to discuss latest advances in cardio-renal-metabolic care
Landmark EMPA-KIDNEY trial showed significant benefit of empagliflozin in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease
Cairo Tower lights up in Blue for World Diabetes Day
Cairo Tower lights up in Blue for World Diabetes Day
Our Partners_ViraTherapeutics
Lisa Egerer, COO and Patrik Erlman, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Listen to the sounds disrupting farms worldwide
A pioneer in Precision Livestock Farming, Prof. Daniel Berckmans reveals how online monitoring technology is bringing healthier pigs closer to farmers and consumers
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages.
World Stroke Organization Honors Eight Stroke Centers powered by Angels Award for their Efforts in developing stroke management in Egypt
World Stroke Organization Honors Eight Stroke Centers powered by Angels Award
COVID-19 Boehringer Ingelheim Clinical Trials
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Stem cells a new frontier
Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
Afrika Kommt! - The Ripple Effect
What the Afrika Kommt! Fellowship Program means to Boehringer Ingelheim
COVID-19 and Type 2 diabetes Regional experts shed light latest scientific updates and
COVID-19 and Type 2 diabetes: Regional experts shed light on the latest scientific updates and clinical practices in disease management for patient education